Comparison of Prasugrel and Clopidogrel Used as Antiplatelet Medication for Endovascular Treatment of Unruptured Intracranial Aneurysms: A Meta-Analysis.
Federico CagnazzoPaolo PerriniPierre-Henri LefevreGregory GascouCyril DargazanliC RiquelmeImad DerrazDavide Tiziano Di CarloAlain BonafeVincent CostalatPublished in: AJNR. American journal of neuroradiology (2019)
In our study, low-dose prasugrel compared with clopidogrel premedication was associated with an effective reduction of the ischemic events with an acceptable rate of hemorrhagic complications.
Keyphrases
- percutaneous coronary intervention
- endovascular treatment
- low dose
- acute coronary syndrome
- antiplatelet therapy
- coronary artery disease
- healthcare
- risk factors
- high dose
- middle cerebral artery
- emergency department
- ischemia reperfusion injury
- adverse drug
- oxidative stress
- blood brain barrier
- brain injury
- electronic health record